FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Taro Pharmaceuticals U.S.A. Kamedis BIO-HERBAL DANDRUFF CARE THERAPEUTIC Recall

Kamedis BIO-HERBAL DANDRUFF CARE THERAPEUTIC 2-STEP DANDRUFF CARE SYSTEM - Kamedis Bio-…

Taro Pharmaceuticals U.S.A., Inc. · Hawthorne, NY

Risk level
Class III
Reported by FDA
Nov 16, 2016
Recall ID
D-0134-2017
Check your lot numberHow we source this data

Summary

Taro Pharmaceuticals U.S.A. recalled Kamedis BIO-HERBAL DANDRUFF CARE THERAPEUTIC starting May 26, 2016. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0134-2017 on Nov 16, 2016. Reason: Subpotent Drug: Out of Specification assay values on stability for the active ingredient, zinc pyrithione. Status: Terminated.

Why it was recalled

Subpotent Drug: Out of Specification assay values on stability for the active ingredient, zinc pyrithione.

Product description

Kamedis BIO-HERBAL DANDRUFF CARE THERAPEUTIC 2-STEP DANDRUFF CARE SYSTEM - Kamedis Bio-Herbal Dandruff Care 0.1% PYRITHIONE ZINC, STEP 1 PRE-TREAT Concentrated Botanical Scalp Lotion (0.1% Pyrithione Zinc) 4.20 FL OZ (125mL) (NDC 51672-2126-0) and STEP 2 CLEANSE Concentrated Botanical Dandruff Shampoo (1.0% Pyrithione Zinc)(0.6.80 FL OZ (200 mL) (NDC 51672-2125-5), Distributed by: Taro Pharmaceuticals U.S.A, Inc. Hawthorne, NY 10532. NDC

Lot numbers, UPCs & expiration codes

Lot #: E601, E602, E603, E604, E608, E609 - Exp. September 2017; E610 E611, Exp. October 2017

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0134-2017
Classification
Class III
Status
Terminated
Recall initiated
May 26, 2016
FDA report date
Nov 16, 2016
Quantity
17,100 kits
Recall type
Voluntary: Firm initiated
Recalling firm
Taro Pharmaceuticals U.S.A., Inc.

Original FDA data

Every field from FDA enforcement report D-0134-2017, exactly as published.

Show all FDA fields
City
Hawthorne
State
NY
Status
Terminated
Country
United States
Event ID
74730
Address
3 Skyline Dr
Code information
Lot #: E601, E602, E603, E604, E608, E609 - Exp. September 2017; E610 E611, Exp. October 2017
Postal code
10532-2174
Report date
Nov 16, 2016
Product type
Drugs
Recall number
D-0134-2017
Classification
Class III
Recalling firm
Taro Pharmaceuticals U.S.A., Inc.
Product quantity
17,100 kits
Termination date
Jun 6, 2018
Reason for recall
Subpotent Drug: Out of Specification assay values on stability for the active ingredient, zinc pyrithione.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Kamedis BIO-HERBAL DANDRUFF CARE THERAPEUTIC 2-STEP DANDRUFF CARE SYSTEM - Kamedis Bio-Herbal Dandruff Care 0.1% PYRITHIONE ZINC, STEP 1 PRE-TREAT Concentrated Botanical Scalp Lotion (0.1% Pyrithione Zinc) 4.20 FL OZ (125mL) (NDC 51672-2126-0) and STEP 2 CLEANSE Concentrated Botanical Dandruff Shampoo (1.0% Pyrithione Zinc)(0.6.80 FL OZ (200 mL) (NDC 51672-2125-5), Distributed by: Taro Pharmaceuticals U.S.A, Inc. Hawthorne, NY 10532. NDC
Distribution pattern
Nationwide
Recall initiation date
May 26, 2016
Initial firm notification
Letter
Center classification date
Nov 10, 2016

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0134-2017, published Nov 16, 2016. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls